From Protocol to Practice: EuroIntervention’s Role in ESC Hot Line 7
Davide Capodanno, Professor of Cardiology at University of Catania, Italy has posted on X:
“To all enthusiasts of platelets, hemostasis, and thrombosis: ESC Hot Line Session 7, focused on antiplatelet therapy in ACS/PCI, is notable for the coincidental fact that all featured trials had their protocol designs published in EuroIntervention. This is gratifying, as it reflects both the trust of leading investigators and the effectiveness of our radar at an early stage.
NEO-MINDSET – Early aspirin withdrawal after PCI for ACS: read more here.
TAILORED-CHIP – Personalized antiplatelet therapy in complex high-risk PCI: read more here.
TARGET-FIRST – Early aspirin discontinuation post-PCI in acute MI: read more here.
DAPT-SHOCK-AMI – Cangrelor in cardiogenic shock: read more here.”
Explore more on Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch